Cancer survival in New South Wales, Australia: socioeconomic disparities remain despite overall improvements

BMC Cancer

Table 3 Number of lives that might be extended beyond 5 years from diagnosis for 10 cancers in NSW, Australia 1996–2000 and 2004–2008

Cancer	Number of lives potentially extended						p-value ^c
	1996–2000			2004–2008
	Number of excess deaths	Lives potentially extended^b	Proportion of excess deaths (%)	Number of excess deaths	Lives potentially extended^b	Proportion of excess deaths (%)
Stomach	1967	316	16.1	1895	324	17.1	0.389
Colorectum	6069	443	7.3	6189	606	9.8	<0.001
Liver	739	137	18.6	1312	312	23.8	0.006
Lung	9729	1090	11.2	11,002	1779	16.2	<0.001
Melanoma	941	0^a	0	1213	0^a	0
Breast	2188	393	17.9	1855	472	25.5	<0.001
Cervix	388	0^a	0	318	92	28.9	<0.001
Uterus	356	0^a	0	474	256	54.0	<0.001
Ovary	970	0^a	0	1051	0^a	0
Prostate	2073	311	15.0	1275	411	32.3	<0.001
All of the above	25,420	2690	10.6	26,583	4253	16.0	<0.001

^aRER coefficients are not significant in the relative survival model for specific cancer
^bEstimated by equating the RER of death due to cancer in the four more disadvantaged SES quintiles to that of the least disadvantaged quintile and calculating the difference in number of cancer deaths
^cPearson chi-square test of the difference between proportions of excess deaths over time (two periods)

ISSN: 1471-2407